Tags: Drug.

Epoetin alfa (rINN) /ɛˈpoʊ.ɨtɨn/ is human erythropoietin produced in cell culture using recombinant DNA technology. Authorised by the European Medicines Agency on 28 August 2007 it stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. Its annual cost to U.S.

Loading...

This page contains content from the copyrighted Wikipedia article "Epoetin alfa"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.